Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis
The current tuberculosis (TB) vaccine, Mycobacterium bovis Bacillus Calmette-Guérin (BCG), provides insufficient protection against pulmonary TB. Previously, we generated a listeriolysin-expressing recombinant BCG strain, which to date has successfully completed phase I and phase IIa clinical trials...
Main Authors: | Gengenbacher, Martin, Nieuwenhuizen, Natalie, Vogelzang, Alexis, Liu, Haipeng, Kaiser, Peggy, Schuerer, Stefanie, Lazar, Doris, Wagner, Ina, Mollenkopf, Hans-Joachim, Kaufmann, Stefan H. E. |
---|---|
Format: | Online |
Language: | English |
Published: |
American Society for Microbiology
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895111/ |
Similar Items
-
Dietary Pyridoxine Controls Efficacy of Vitamin B6-Auxotrophic Tuberculosis Vaccine Bacillus Calmette-Guérin ΔureC::hly Δpdx1 in Mice
by: Gengenbacher, Martin, et al.
Published: (2014) -
The Tuberculosis Vaccine Candidate Bacillus Calmette-Guérin ΔureC::hly Coexpressing Human Interleukin-7 or -18 Enhances Antigen-Specific T Cell Responses in Mice
by: Rao, Martin, et al.
Published: (2013) -
Central Memory CD4+ T Cells Are Responsible for the Recombinant Bacillus Calmette-Guérin ΔureC::hly Vaccine's Superior Protection Against Tuberculosis
by: Vogelzang, Alexis, et al.
Published: (2014) -
Recombinant BCG ΔureC hly+ Induces Superior Protection Over Parental BCG by Stimulating a Balanced Combination of Type 1 and Type 17 Cytokine Responses
by: Desel, Christiane, et al.
Published: (2011) -
Mycobacterium tuberculosis nuoG Is a Virulence Gene That Inhibits Apoptosis of Infected Host Cells
by: Velmurugan, Kamalakannan, et al.
Published: (2007)